XT
SPRB

XTX Topco’s Spruce Biosciences SPRB Stock Holding History

XTX Topco’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-550
Closed -$12K – 3379
2025
Q1 		$12K Buy
550
+76
+16% +$2.12K ﹤0.01% 2227
2024
Q4 		$14.9K Buy
474
+219
+86% +$8.03K ﹤0.01% 2090
2024
Q3 		$9.09K Sell
255
-107
-30% -$3.92K ﹤0.01% 1934
2024
Q2 		$14.1K Sell
362
-395
-52% -$21.2K ﹤0.01% 1656
2024
Q1 		$44.6K Buy
+757
New +$192K 0.01% 1485

Other funds holding SPRB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

XTX Topco's SPRB Position: Q2 2025 in Review

XTX Topco sold out of Spruce Biosciences (SPRB) in Q2 2025, closing a stake of 550 shares — an estimated $12K sold.

XTX Topco first reported a position in SPRB in Q1 2024 and held it in 5 quarters. The position peaked at $44.6K in Q1 2024. 3 funds tracked by Wall St. Rank hold SPRB as of Q2 2025.

  • XTX Topco reported no remaining Spruce Biosciences position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 550 Spruce Biosciences shares in Q2 2025, an estimated $12K.
  • XTX Topco first reported a position in Spruce Biosciences in Q1 2024 and held it in 5 quarters.
  • XTX Topco's Spruce Biosciences position peaked at $44.6K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.